RGEN Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
209.3M
+2.5%
204.1M
+5.1%
194.3M
-1.8%
197.9M
+4.8%
188.8M
Cost of Revenue
98.3M
+4.5%
94.1M
+9.4%
86.0M
-8.6%
94.1M
+6.6%
88.3M
Gross Profit
111.0M
+0.9%
110.0M
+1.6%
108.3M
+4.3%
103.8M
+3.3%
100.5M
Operating Expenses
140.5M
+46.3%
96.1M
+4.0%
92.3M
+7.4%
86.0M
+2.7%
83.7M
R&D
14.4M
+0.1%
14.4M
-0.3%
14.5M
+10.2%
13.1M
-7.4%
14.2M
SG&A
83.6M
+9.1%
76.6M
+0.1%
76.5M
+2.9%
74.4M
+1.0%
73.7M
Operating Income
-29546000
-311.4%
14.0M
-12.3%
15.9M
-10.8%
17.9M
+6.2%
16.8M
EBITDA
32.8M
-13.9%
38.1M
+2.7%
37.1M
-3.3%
38.3M
+1.1%
37.9M
Net Income
-38432000
-867.4%
5.0M
-39.9%
8.3M
-37.3%
13.3M
-10.9%
14.9M
EPS (Basic)
$-0.68
-855.6%
$0.09
-40.0%
$0.15
-37.5%
$0.24
-11.1%
$0.27
EPS (Diluted)
$-0.68
-855.6%
$0.09
-40.0%
$0.15
-34.8%
$0.23
-11.5%
$0.26
Shares (Diluted)
56.6M
-0.1%
56.6M
-0.0%
56.7M
+0.0%
56.6M
+0.2%
56.5M
Repligen (RGEN) — Financials